Notable
Stage
AcquiredTotal Raised
$68.49MInvestors Count
25Deal Terms
2Portfolio Exits
1Investments
2Funding, Valuation & Revenue
13 Fundings
Notable has raised $68.49M over 13 rounds.
Notable's latest funding round was a Reverse Merger for on October 17, 2023.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/17/2023 | Reverse Merger | 3 | ||||
2/25/2023 | Series D | |||||
7/15/2022 | Series C | $10.3M | 2 | |||
2/23/2022 | Angel | |||||
4/12/2020 | Loan |
Date | 10/17/2023 | 2/25/2023 | 7/15/2022 | 2/23/2022 | 4/12/2020 |
|---|---|---|---|---|---|
Round | Reverse Merger | Series D | Series C | Angel | Loan |
Amount | $10.3M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 3 | 2 |
Notable Deal Terms
2 Deal Terms
Notable's deal structure is available for 2 funding rounds, including their Series A from August 31, 2017.
Round | Series A | Seed VC |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A | |||||||||||||||
Seed VC |
Notable Investors
25 Investors
Notable has 25 investors. VBL Therapeutics invested in Notable's Reverse Merger funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/17/2023 | 10/17/2023 | 1 Reverse Merger | Corporation | Israel | ||
5/17/2016 | 2/25/2023 | 6 Seed VC - II, Series A (2017), Bridge (2018), Series B (2019), Series C (2022), Series D (2023) | Venture Capital | California | ||
9/1/2015 | 7/15/2022 | 3 Seed VC, Series A (2017), Series C (2022) | Venture Capital | Pennsylvania | ||
Venture Capital | California | |||||
Venture Capital | California |
First funding | 10/17/2023 | 5/17/2016 | 9/1/2015 | ||
|---|---|---|---|---|---|
Last Funding | 10/17/2023 | 2/25/2023 | 7/15/2022 | ||
Investor | |||||
Rounds | 1 Reverse Merger | 6 Seed VC - II, Series A (2017), Bridge (2018), Series B (2019), Series C (2022), Series D (2023) | 3 Seed VC, Series A (2017), Series C (2022) | ||
Board Seats | |||||
Type | Corporation | Venture Capital | Venture Capital | Venture Capital | Venture Capital |
Location | Israel | California | Pennsylvania | California | California |
Notable Investments
2 Investments
Notable has made 2 investments. Their latest investment was in Labcyte as part of their Series E on January 09, 2017.
Notable Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/9/2017 | Series E | Labcyte | $5M | Yes | 2 | |
3/15/2016 | Seed VC |
Date | 1/9/2017 | 3/15/2016 |
|---|---|---|
Round | Series E | Seed VC |
Company | Labcyte | |
Amount | $5M | |
New? | Yes | |
Co-Investors | ||
Sources | 2 |
Notable Portfolio Exits
1 Portfolio Exit
Notable has 1 portfolio exit. Their latest portfolio exit was Labcyte on January 30, 2019.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
1/30/2019 | Acquired | 1 |
Date | 1/30/2019 |
|---|---|
Exit | Acquired |
Companies | |
Valuation | |
Acquirer | |
Sources | 1 |
Compare Notable to Competitors
Dedalus provides healthcare and diagnostic software solutions. The company offers products and services that support the digital transformation of healthcare organizations, including electronic health records, diagnostic imaging information technology (IT), and healthcare platform services. Dedalus serves the healthcare sector, providing solutions that assist in care provision. It was founded in 1982 and is based in Milan, Italy.
Praxis EMR provides Electronic Health Records (EHR) systems in the healthcare sector. The company offers an EHR solution that utilizes artificial intelligence to enable electronic charting, allowing for template-free documentation and personalized patient notes. Praxis EMR serves medical providers looking for EHR technology. It is based in Los Angeles, California.
NextGen Healthcare is a software and services company. It focuses on healthcare technology and data solutions, specifically in electronic health records, practice management, and revenue cycle management within the healthcare sector. It provides products to improve clinical quality, productivity, and financial performance for ambulatory practices. It offers documentation tools, patient and provider experience tools, and analytics to support value-based care and interoperability. It was founded in 1974 and is based in Atlanta, Georgia.
Epic focuses on developing healthcare software within the health information technology (IT) industry. Its main offerings include coding, testing, and implementing software solutions. Epic's products are utilized by healthcare professionals. Epic was formerly known as Human Services Computing. It was founded in 1979 and is based in Verona, Wisconsin.
athenahealth operates as a company providing healthcare technology solutions, including electronic health records, medical billing and practice management software, and patient engagement tools. The offerings aim to improve operations and patient care. athenahealth serves a variety of customers, including provider organizations, medical practices of different sizes, health systems, and healthcare payers. It was founded in 1997 and is based in Boston, Massachusetts.
Hippocratic AI develops large language models for the healthcare sector, focusing on safety in generative artificial intelligence (AI). The company provides AI agents aimed at supporting healthcare accessibility and addressing health outcomes, integrating healthcare expertise. These AI solutions are applicable to different segments in the healthcare industry, including payors, pharmaceuticals, dental, and providers. It was founded in 2023 and is based in Palo Alto, California.
Loading...